JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M701596200 on September 4, 2007

J. Biol. Chem., Vol. 282, Issue 44, 31990-31999, November 2, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/44/31990    most recent
M701596200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kauskot, A.
Right arrow Articles by Bryckaert, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kauskot, A.
Right arrow Articles by Bryckaert, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Involvement of the Mitogen-activated Protein Kinase c-Jun NH2-terminal Kinase 1 in Thrombus Formation*

Alexandre Kauskot{ddagger}§12, Frédéric Adam{ddagger}23, Alexandra Mazharian{ddagger}§, Nadine Ajzenberg||, Eliane Berrou{ddagger}§, Arnaud Bonnefoy**, Jean-Philippe Rosa{ddagger}§, Marc F. Hoylaerts{ddagger}{ddagger}, and Marijke Bryckaert{ddagger}§4

From the {ddagger}Centre de Recherche Cardiovasculaire INSERM Lariboisière, U689-E4, Hôpital Lariboisière, 8 rue Guy Patin, 75010 Paris, France, U698 INSERM, Hôpital X. Bichat, 75018 Paris, France, **U743 INSERM, Montréal, Quebec H2X 1P1, Canada, the {ddagger}{ddagger}Center for Molecular and Vascular Biology, University of Leuven, 3000 Leuven, Belgium, ||Hématologie et immunologie, Hôpital X. Bichat, AP-HP, 75018 Paris, France, and §Université Paris VII Denis Diderot, 75013 Paris, France

The involvement of the mitogen-activated protein kinase c-Jun NH2-terminal kinase-1 (JNK1) has never been investigated in hemostasis and thrombosis. Using two JNK inhibitors (SP600125 and 6o), we have demonstrated that JNK1 is involved in collagen-induced platelet aggregation dependent on ADP. In these conditions, JNK1 activation requires the coordinated signaling pathways of collagen receptors ({alpha}2beta1 and glycoprotein (GP)VI) and ADP. In contrast, JNK1 is not required for platelet adhesion on a collagen matrix in static or blood flow conditions (300–1500 s–1) involving collagen receptors ({alpha}2beta1 and GPVI). Importantly, at 1500 s–1, JNK1 acts on thrombus formation on a collagen matrix dependent on GPIb-von Willebrand factor (vWF) interaction but not ADP receptor activation. This is confirmed by the involvement of JNK1 in shear-induced platelet aggregation at 4000 s–1. We also provide evidence during rolling and adhesion of platelets to vWF that platelet GPIb-vWF interaction triggers {alpha}IIbbeta3 activation in a JNK1-dependent manner. This was confirmed with a Glanzmann thrombastenic patient lacking {alpha}IIbbeta3. Finally, in vivo, JNK1 is involved in arterial but not in venular thrombosis in mice. Overall, our in vitro studies define a new role of JNK1 in thrombus formation in flowing blood that is relevant to thrombus development in vivo.


Received for publication, February 23, 2007 , and in revised form, September 4, 2007.

* This work was supported by l'Institut National de la Santé et de la Recherche Médicale (INSERM) and l'Agence Nationale de la Recherche (ANR). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Recipient of a Ph. D. fellowship from the Ministère de l'Enseignement et de la Recherche.

2 These authors contributed equally to this work.

3 Frédéric Adam was supported by Agence Nationale de la Recherche (ANR).

4 To whom correspondence should be addressed: Hôpital Lariboisière, U689-E4 INSERM, 8 rue Guy Patin, 75010 Paris, France. Tel.: 33-1-53-21-67-81; Fax: 33-1-53-21-67-39; E-mail: marijke.bryckaert{at}larib.inserm.fr.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
K. Chen, M. Febbraio, W. Li, and R. L. Silverstein
A Specific CD36-Dependent Signaling Pathway Is Required for Platelet Activation by Oxidized Low-Density Lipoprotein
Circ. Res., June 20, 2008; 102(12): 1512 - 1519.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.